Subcutaneous Pharmacokinetics of Belatacept

NCT00569803 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Transplantation

Interventions

DRUG: belatacept
DRUG: Placebo

Sponsor

Bristol-Myers Squibb